RESUMEN
Background: Liver kinase B1 ( LKB1 ) is a tumor suppressor in lung adenocarcinoma (LADC). We investigated the proteomic profiles of 45 LADC cell lines with and without LKB1 inactivation. Carbamoyl phosphate synthetase 1 (CPS1), the first rate-limiting mitochondrial enzyme in the urea cycle, was distinctively overexpressed in LKB1-inactivated LADC cell lines. We therefore assessed the role of CPS1 and its clinical relevance in LKB1-inactivated LADC. Methods: Mass spectrometric profiling of proteome and metabolome and function of CPS1 were analyzed in LADC cell lines. CPS1 and LKB1 expression in tumors from 305 LADC and 160 lung squamous cell carcinoma patients was evaluated by immunohistochemistry. Kaplan-Meier and Cox regression analyses were applied to assess the association between overall survival and CPS1 and LKB1 expression. All statistical tests were two-sided. Results: CPS1 knockdown reduced cell growth, decreased metabolite levels associated with nucleic acid biosynthesis pathway, and contributed an additive effect when combined with gemcitabine, pemetrexed, or CHK1 inhibitor AZD7762. Tissue microarray analysis revealed that CPS1 was expressed in 65.7% of LKB1-negative LADC, and only 5.0% of LKB1-positive LADC. CPS1 expression showed statistically significant association with poor overall survival in LADC (hazard ratio = 3.03, 95% confidence interval = 1.74 to 5.25, P < .001). Conclusions: Our findings suggest functional relevance of CPS1 in LKB1-inactivated LADC and association with worse outcome of LADC. CPS1 is a promising therapeutic target in combination with other chemotherapy agents, as well as a prognostic biomarker, enabling a personalized approach to treatment of LADC.
Asunto(s)
Adenocarcinoma/metabolismo , Carbamoil-Fosfato Sintasa (Amoniaco)/metabolismo , Carcinoma de Células Escamosas/química , Neoplasias Pulmonares/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Quinasas de la Proteína-Quinasa Activada por el AMP , Adenocarcinoma/química , Anciano , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/genética , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Desoxicitidina/análogos & derivados , Desoxicitidina/farmacología , Femenino , Técnicas de Silenciamiento del Gen , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/química , Masculino , Redes y Vías Metabólicas , Metaboloma/efectos de los fármacos , Persona de Mediana Edad , Pemetrexed/farmacología , Pronóstico , Modelos de Riesgos Proporcionales , Proteínas Serina-Treonina Quinasas/análisis , Proteínas Serina-Treonina Quinasas/genética , Proteoma , ARN Mensajero/metabolismo , Transducción de Señal , Tasa de Supervivencia , Tiofenos/farmacología , Análisis de Matrices Tisulares , Urea/análogos & derivados , Urea/farmacología , GemcitabinaRESUMEN
We had previously shown that alcohol consumption can induce cellular isoaspartate protein damage via an impairment of the activity of protein isoaspartyl methyltransferase (PIMT), an enzyme that triggers repair of isoaspartate protein damage. To further investigate the mechanism of isoaspartate accumulation, hepatocytes cultured from control or 4-week ethanol-fed rats were incubated in vitro with tubercidin or adenosine. Both these agents, known to elevate intracellular S-adenosylhomocysteine levels, increased cellular isoaspartate damage over that recorded following ethanol consumption in vivo. Increased isoaspartate damage was attenuated by treatment with betaine. To characterize isoaspartate-damaged proteins that accumulate after ethanol administration, rat liver cytosolic proteins were methylated using exogenous PIMT and (3)H-S-adenosylmethionine and proteins resolved by gel electrophoresis. Three major protein bands of â¼ 75-80 kDa, â¼ 95-100 kDa, and â¼ 155-160 kDa were identified by autoradiography. Column chromatography used to enrich isoaspartate-damaged proteins indicated that damaged proteins from ethanol-fed rats were similar to those that accrued in the livers of PIMT knockout (KO) mice. Carbamoyl phosphate synthase-1 (CPS-1) was partially purified and identified as the â¼ 160 kDa protein target of PIMT in ethanol-fed rats and in PIMT KO mice. Analysis of the liver proteome of 4-week ethanol-fed rats and PIMT KO mice demonstrated elevated cytosolic CPS-1 and betaine homocysteine S-methyltransferase-1 when compared to their respective controls, and a significant reduction of carbonic anhydrase-III (CA-III) evident only in ethanol-fed rats. Ethanol feeding of rats for 8 weeks resulted in a larger (â¼ 2.3-fold) increase in CPS-1 levels compared to 4-week ethanol feeding indicating that CPS-1 accumulation correlated with the duration of ethanol consumption. Collectively, our results suggest that elevated isoaspartate and CPS-1, and reduced CA-III levels could serve as biomarkers of hepatocellular injury.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Anhidrasa Carbónica III/análisis , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Ácido Isoaspártico/análisis , Hígado/patología , Proteína D-Aspartato-L-Isoaspartato Metiltransferasa/metabolismo , Animales , Biomarcadores/análisis , Biomarcadores/metabolismo , Carbamoil-Fosfato Sintasa (Amoniaco)/metabolismo , Anhidrasa Carbónica III/metabolismo , Células Cultivadas , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Etanol/efectos adversos , Ácido Isoaspártico/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Ratones Noqueados , Proteína D-Aspartato-L-Isoaspartato Metiltransferasa/genética , Ratas , Ratas Wistar , S-Adenosilhomocisteína/metabolismoRESUMEN
Albumin, widely recognized as a highly sensitive and specific marker of hepatocellular carcinoma (HCC), is currently unavailable in the diagnostic laboratory because of the lack of a robust platform. In a prior study we detected albumin mRNA in the majority of intrahepatic cholangiocarcinomas using a novel branched chain RNA in situ hybridization (ISH) platform. We now explore the utility of albumin ISH as a marker of hepatocellular differentiation in HCCs, and compare its sensitivity with Hep Par 1 and Arginase-1. We evaluated 93 HCCs and its mimics including neuroendocrine tumors of the gastrointestinal tract (n=31), neuroendocrine tumors of the pancreas (n=163), melanoma (n=15), and gallbladder carcinoma (n=34). We performed ISH for albumin and immunohistochemistry for Hep Par 1 and Arginase-1. Five previously uncharacterized hepatic neoplasms from our files were also evaluated. Immunohistochemistry for Arginase-1 was performed on 59 intrahepatic cholangiocarcinomas. In addition, 43 HCCs evaluated on the manual platform were also examined on the automated instrument. Fifty-five percent of HCCs were moderately differentiated and 39% poorly differentiated. The sensitivity of ISH for albumin was 99%, with 92 of 93 HCCs staining positive for albumin. In contrast to ISH, the sensitivity of immunohistochemistry for Hep Par 1 and Arginase-1 was 84% and 83%, respectively. The sensitivity of albumin for poorly differentiated HCCs was 99%, whereas that for Arginase-1 and Hep Par 1 was 71% and 64%, respectively. Ninety-seven percent of the HCCs showed albumin positivity in >50% of tumor cells using the ISH platform, as compared with 76% and 70% for Hep Par 1 and Arginase-1 immunohistochemistry, respectively. Three of the 5 previously uncharacterized neoplasms were positive for albumin ISH. Automated albumin ISH platform performed equivalently to the manual format, with albumin reactivity in >50% of tumor cells in all 43 cases that were tested on both platforms. All non-HCCs were negative for albumin. All 59 intrahepatic cholangiocarcinomas were negative for Arginase-1. In conclusion, branched chain ISH performed on manual and automated mode is a robust assay for detecting albumin with sensitivity for poorly differentiated HCCs superior to Arginase-1 and Hep Par 1. When interpreted in conjunction with Arginase-1, albumin ISH offers a high level of sensitivity and specificity.
Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma Hepatocelular/genética , Diferenciación Celular , Hibridación in Situ/métodos , Neoplasias Hepáticas/genética , ARN Mensajero/genética , Albúmina Sérica/genética , Anciano , Anciano de 80 o más Años , Arginasa/análisis , Automatización de Laboratorios , Biopsia , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carcinoma Hepatocelular/química , Carcinoma Hepatocelular/patología , Diagnóstico Diferencial , Inglaterra , Femenino , Humanos , Inmunohistoquímica , Neoplasias Hepáticas/química , Neoplasias Hepáticas/patología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Albúmina Sérica Humana , Análisis de Matrices Tisulares , Estados UnidosRESUMEN
INTRODUCTION: We have previously differentiated hepatocyte like cells from deciduous tooth pulp stem and extracted third molar pulp stem cells with a protocol that used fetal bovine serum, but it showed high contaminations of nondifferentiated cells. Both the lower purity of hepatically differentiated cells and usage of serum are obstacles for application of cell therapy or regenerative medicine. Objective of this study was to investigate the capacity for and purity of hepatocyte-like differentiation of CD117-positive dental pulp stem cells without serum. METHODS: Mesenchymal cells from human deciduous and extracted third molar pulp were isolated and expanded in vitro. We separated CD117-positive cells by using a magnetic-activated cell sorter. The cells were characterized immunofluorescently by using known stem cell markers. For hepatic differentiation, the media were supplemented with hepatic growth factor, insulin-transferrin-selenium-x, dexamethasone, and oncostatin M. Expression of hepatic markers alpha fetoprotein, albumin, hepatic nuclear factor-4 alpha, insulin-like growth factor-1, and carbamoyl phosphate synthetase was examined immunofluorescently after differentiation. The amount of differentiated cells was assessed by using flow cytometry. Glycogen storage and urea concentration in the medium were defined. RESULTS: Both cell cultures demonstrated a number of cells positive for all tested hepatic markers after differentiation, ie, albumin-positive cells were almost 90% of differentiated deciduous pulp cells. The concentration of urea in the media increased significantly after differentiation. Significant amount of cytoplasmic glycogen storage was found in the cells. CONCLUSIONS: Without serum both cell types differentiated into high-purity hepatocyte-like cells. These cells offer a source for hepatocyte lineage differentiation for transplantation in the future.
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Pulpa Dental/citología , Hepatocitos/fisiología , Células Madre/fisiología , Biomarcadores/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Diferenciación Celular , Linaje de la Célula , Medio de Cultivo Libre de Suero , Dexametasona/farmacología , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Glucocorticoides/farmacología , Glucógeno/análisis , Inhibidores de Crecimiento/farmacología , Factor de Crecimiento de Hepatocito/farmacología , Factor Nuclear 4 del Hepatocito/análisis , Humanos , Insulina/farmacología , Factor I del Crecimiento Similar a la Insulina/análisis , Oncostatina M/farmacología , Proteínas Proto-Oncogénicas c-kit/análisis , Selenio/farmacología , Albúmina Sérica/análisis , Transferrina/farmacología , Urea/análisis , alfa-Fetoproteínas/análisisRESUMEN
Arginine biosynthesis in eukaryotes is divided between the mitochondria and the cytosol. The anaerobic chytridiomycete Neocallimastix frontalis contains highly reduced, anaerobic modifications of mitochondria, the hydrogenosomes. Hydrogenosomes also occur in the microaerophilic flagellate Trichomonas vaginalis, which does not produce arginine but uses one of the mitochondrial enzymes, ornithine transcarbamoylase, in a cytosolic arginine dihydrolase pathway for ATP generation. EST sequencing and analysis of the hydrogenosomal proteome of N. frontalis provided evidence for two mitochondrial enzymes of arginine biosynthesis, carbamoylphosphate synthase and ornithine transcarbamoylase, while activities of the arginine dehydrolase pathway enzymes were not detectable in this fungus.
Asunto(s)
Arginina/biosíntesis , Neocallimastix/metabolismo , Orgánulos/metabolismo , Secuencia de Aminoácidos , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/química , ADN Complementario , Etiquetas de Secuencia Expresada , Proteínas Fúngicas , Biblioteca de Genes , Datos de Secuencia Molecular , Neocallimastix/enzimología , Orgánulos/química , Ornitina Carbamoiltransferasa/análisis , Ornitina Carbamoiltransferasa/química , Proteoma , Alineación de SecuenciaRESUMEN
The effects of toxic and nontoxic compound treatments were investigated by high resolution custom developed 2-11 pH gradient NEPHGE (non equilibrium pH gradient electrophoresis) two-dimensional electrophoresis. Two models were compared: (i) in vivo rat and (ii) the human cell line HepG2, to test their suitability in a proteomics based approach to identify a toxicity marker. 163 and 321 proteins were identified from the rat liver and the HepG2 proteome. These represent various isoforms of 113 and 194 different NCBI annotated gene sequences, respectively. Nine compounds were selected to induce proteome variations associated with liver toxicity and metabolism. The rat liver proteome database consists of 78 gels, the HepG2 database of 52 gels. Variant proteins were assessed regarding their usefulness as a toxicity marker by evaluating their treatment specificity against multiple control treatments. Thirteen potential toxicity marker proteins were found in rat liver and eight in HepG2. Catalase and carbamoylphosphate synthetase-1 isoforms were found to be significantly changed after treatment by 4/4 and 3/4 toxic compounds in rat liver, respectively. Aldo-keto-reductase family 1, member C1 was implicated for 3/4 liver cell toxic compounds in HepG2. Our approach was able to differentiate the quality of potential toxicity markers and provided useful information for an ongoing characterization of more compounds in a wider number of toxicity classes.
Asunto(s)
Hígado/efectos de los fármacos , Proteoma/efectos de los fármacos , Proteómica , 1-Naftilisotiocianato/farmacología , 1-Naftilisotiocianato/toxicidad , Acetaminofén/farmacología , Acetaminofén/toxicidad , Oxidorreductasas de Alcohol/análisis , Aldehído Reductasa , Aldo-Ceto Reductasas , Animales , Biomarcadores/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Catalasa/análisis , Línea Celular Tumoral , Cisplatino/farmacología , Cisplatino/toxicidad , Bases de Datos de Proteínas , Dimetilnitrosamina/farmacología , Dimetilnitrosamina/toxicidad , Electroforesis en Gel Bidimensional , Hexoquinasa/análisis , Humanos , Indometacina/farmacología , Indometacina/toxicidad , Punto Isoeléctrico , Hígado/química , Hígado/patología , Masculino , Peso Molecular , Isoformas de Proteínas/análisis , Proteínas/análisis , Proteoma/análisis , Ratas , Ratas Sprague-Dawley , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Tetraciclina/farmacología , Tetraciclina/toxicidadRESUMEN
The objective of this study was to investigate the expression of carbamoylphosphate synthetase I (CPS) and glutamine synthetase (GS) in small hepatocyte colonies and whether the heterogeneous expression of the enzymes could be induced during the maturation of small hepatocytes. Small hepatocytes isolated from an adult rat liver were cultured and proliferated to form colonies. The expression of CPS and GS was examined using immunocytochemistry and immunoblotting. In this culture more than 99% of morphologically hepatic cells were positive for CPS and all small hepatocytes were negative for GS at day 5. CPS-positive cells dramatically decreased with time in culture, whereas GS-positive ones appeared and their number increased in the colonies. Two to 3 weeks after plating, colonies with rising and piled-up cells appeared and the number of such colonies reached about 25% of all colonies at day 30. In most rising and piled-up cells in colonies both proteins were strongly expressed, whereas many small hepatocytes in monolayer colonies did not express either protein. When small hepatocytes in monolayer colonies were overlayed with Matrigel, the cells gradually piled up and both CPS and GS proteins were dramatically induced. The expression of CPS and GS in small hepatocytes may interact with the extracellular matrix because the rising and piled-up cells appear to be induced by the extracellular matrix produced by hepatic nonparenchymal cells.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/biosíntesis , Glutamato-Amoníaco Ligasa/biosíntesis , Hepatocitos/enzimología , Animales , Materiales Biocompatibles , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Células Cultivadas , Colágeno , Combinación de Medicamentos , Matriz Extracelular/enzimología , Glutamato-Amoníaco Ligasa/análisis , Hepatocitos/citología , Inmunohistoquímica , Laminina , Masculino , Proteoglicanos , Ratas , Ratas Sprague-DawleyRESUMEN
Development of desmin-positive hepatic stellate cells was studied in mice using double immunofluorescent techniques and in vitro cultures with special attention given to their cell lineages. Several studies recently reported on the presence of cells that are immunologically reactive with both antidesmin and anticytokeratin antibodies in young fetal rat livers, and suggested the possibility that these cells give rise to hepatocytes and hepatic stellate cells. At early stages of mouse liver development, stellate cells with desmin-positive filaments were scattered in the liver parenchyma. However, the stellate cells definitely differed from hepatoblasts and hepatocytes in terms of their morphology and expression of desmin and hepatoblast and hepatocyte-specific E-cadherin in the liver. Fetal hepatoblasts and hepatocytes did not react with antidesmin antibodies, nor did desmin-positive stellate cells express E-cadherin in vivo and in vitro. Thus it is likely that desmin-positive stellate cells and hepatoblasts belong to different cell lineages. In the fetal liver, the desmin-positive stellate cells surrounded blood vessels, and extended their processes to haematopoietic cells and megakaryocytes. Many, but not all, hepatoblasts and hepatocytes were observed to be associated with the stellate cells. At fetal stages, cellular processes positive for desmin in the stellate cells were also thick compared with those in the adult liver, in which desmin-positive stellate cells lay in Disse's space and were closely associated with all hepatocytes. These developmental changes in the geography of desmin-positive cells in the liver parenchyma and their morphology may be associated with their maturation and interactions with other cell types.
Asunto(s)
Desmina/análisis , Hepatocitos/metabolismo , Hígado/embriología , Albúminas/análisis , Animales , Cadherinas/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Técnicas de Cultivo de Célula , Linaje de la Célula , Immunoblotting/métodos , Inmunohistoquímica/métodos , Queratinas/análisis , Ratones , Ratones Endogámicos C3H , alfa-Fetoproteínas/análisisRESUMEN
The clinical importance of carbamoyl phosphate synthase I (CPSI) relates to its capacity to metabolize ammonia, because CPSI deficiencies cause lethal serum ammonia levels. Although some metabolic parameters concerning liver and intestinal CPSI have been reported, the extent to which enterocytes contribute to ammonia conversion remains unclear without a detailed description of its developmental and spatial expression patterns. Therefore, we determined the patterns of enterocytic CPSI mRNA and protein expression in human and rat intestine during embryonic and postnatal development, using in situ hybridization and immunohistochemistry. CPSI protein appeared during human embryogenesis in liver at 31-35 e. d. (embryonic days) before intestine (59 e.d.), whereas in rat CPSI detection in intestine (at 16 e.d.) preceded liver (20 e.d.). During all stages of development there was a good correlation between the expression of CPSI protein and mRNA in the intestinal epithelium. Strikingly, duodenal enterocytes in both species exhibited mosaic CPSI protein expression despite uniform CPSI mRNA expression in the epithelium and the presence of functional mitochondria in all epithelial cells. Unlike rat, CPSI in human embryos was expressed in liver before intestine. Although CPSI was primarily regulated at the transcriptional level, CPSI protein appeared mosaic in the duodenum of both species, possibly due to post-transcriptional regulation.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/genética , Duodeno/enzimología , Mucosa Intestinal/enzimología , Adolescente , Envejecimiento/metabolismo , Animales , Niño , Preescolar , Duodeno/embriología , Duodeno/crecimiento & desarrollo , Expresión Génica , Regulación del Desarrollo de la Expresión Génica , Humanos , Inmunohistoquímica , Hibridación in Situ , Lactante , Mucosa Intestinal/embriología , Mucosa Intestinal/crecimiento & desarrollo , Hígado/embriología , Hígado/enzimología , Hígado/crecimiento & desarrollo , Mitocondrias/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Especificidad de la EspecieRESUMEN
The primary mechanisms proposed for acetaminophen-induced hepatic necrosis should deplete protein thiols, either by covalent binding and thioether formation or by oxidative reactions such as S-thiolations. However, in previous studies we did not detect significant losses of protein thiol contents in response to administration of hepatotoxic doses of acetaminophen in vivo. In the present study we employed derivatization with the thiol-specific agent monobromobimane and separation of proteins by SDS-PAGE to investigate the possible loss of specific protein thiols during the course of acetaminophen-induced hepatic necrosis. Fasted adult male mice were given acetaminophen, and protein thiol status was examined subsequently in subcellular fractions isolated by differential centrifugation. No decreases in protein thiol contents were indicated, with the exception of a marked decrease in the fluorescent intensity, but not of protein content, as indicated by staining with Coomassie blue, of a single band of approximately 130 kDa in the mitochondrial fractions of acetaminophen-treated mice. This protein was identified by isolation and N-terminal sequence analysis as carbamyl phosphate synthetase-I (CPS-I) (EC 6.3.4.16). Hepatic CPS-I activities were decreased in mice given hepatotoxic doses of acetaminophen. In addition, hepatic glutamine synthetase activities were lower, and plasma ammonia levels were elevated in mice given hepatotoxic doses of acetaminophen. The observed hyperammonemia may contribute to the adverse effects of toxic doses of acetaminophen, and elucidation of the specific mechanisms responsible for the hyperammonemia may prove to be useful clinically. However, the preferential depletion of protein thiol content of a mitochondrial protein by chemically reactive metabolites generated in the endoplasmic reticulum presents a challenging and potentially informative mechanistic question.
Asunto(s)
Acetaminofén/toxicidad , Analgésicos no Narcóticos/toxicidad , Carbamoil-Fosfato Sintasa (Amoniaco)/antagonistas & inhibidores , Carbamoil-Fosfato Sintasa (Glutamina-Hidrolizante)/antagonistas & inhibidores , Hígado/efectos de los fármacos , Acetaminofén/administración & dosificación , Alanina Transaminasa/sangre , Secuencia de Aminoácidos , Amoníaco/sangre , Analgésicos no Narcóticos/administración & dosificación , Animales , Compuestos Bicíclicos con Puentes , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carbamoil-Fosfato Sintasa (Glutamina-Hidrolizante)/análisis , Fraccionamiento Celular , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Colorantes Fluorescentes , Hígado/enzimología , Masculino , Ratones , Mitocondrias Hepáticas/química , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/enzimología , Datos de Secuencia Molecular , Compuestos de Sulfhidrilo/análisis , Reactivos de Sulfhidrilo/químicaRESUMEN
The basis for the benefit of early treatment in urea-cycle defects might be an increase in intramitochondrial mutant enzyme in hepatocytes in the postnatal period. In two siblings with carbamyl phosphate synthetase I (CPS I) deficiency, immunoreactive CPS I was greatly reduced in the liver and no residual enzyme activity was detectable. The elder child died at age 4 days, before the diagnosis of CPS I deficiency was established, but in the younger child, age 9 months, treatment was initiated on the 2nd day of life when ammonia concentration was moderately increased, and she has survived. Intramitochondrial CPS I was substantially higher in this sibling than in the elder sister. The different outcome in the younger patient was probably attributable to prompt treatment after early diagnosis.
Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/mortalidad , Carbamoil-Fosfato Sintasa (Amoniaco)/deficiencia , Mitocondrias Hepáticas/enzimología , Errores Innatos del Metabolismo de los Aminoácidos/metabolismo , Errores Innatos del Metabolismo de los Aminoácidos/terapia , Amoníaco/sangre , Biopsia , Western Blotting , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Terapia Combinada , Femenino , Humanos , Lactante , Recién Nacido , Hígado/patología , Mitocondrias Hepáticas/química , Factores de TiempoRESUMEN
Carbamoyl phosphate synthetase I, the most abundant protein of rat liver mitochondria, plays a key role in synthesis of urea. Because aging affects some liver functions, and because there is no information on the levels of carbamoyl phosphate synthetase I during aging, we assayed the activity of this enzyme and determined immunologically the level of carbamoyl phosphate synthetase I in liver homogenates from young (4 months) and old (18 or 26 months) rats. In addition, we used electron microscopic immunogold procedures to locate and measure the amount of the enzyme in the mitochondrial matrix. There is no significant change in enzyme activity or enzyme protein content with age, although there is a higher concentration of the enzyme in the mitochondria (c. 1.5 times greater) from old rats, which is compensated by a decrease in the fractional volume of the mitochondrial compartment during aging.
Asunto(s)
Envejecimiento/metabolismo , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Mitocondrias Hepáticas/enzimología , Factores de Edad , Animales , Anticuerpos Monoclonales , Carbamoil-Fosfato Sintasa (Amoniaco)/inmunología , Inmunoensayo , Immunoblotting , Inmunohistoquímica , Masculino , Mitocondrias Hepáticas/ultraestructura , Ratas , Ratas Endogámicas , Conservación de TejidoRESUMEN
In the mammalian liver the distribution of ammonia-detoxifying enzymes, glutamine synthetase (GS) and carbamoylphosphate synthase I (ammonia) (CPS-I), is mutually exclusive in that these enzymes are expressed in two distinct populations of hepatocytes that are zonally demarcated in the liver acinus. In the present study we examined the distribution of GS and CPS-I in pancreatic hepatocytes to ascertain if the expression of these two genes in these hepatocytes is also mutually exclusive. Multiple foci of hepatocytes showing no clear acinar organization develop in the adult rat pancreas as a result of a change in the differentiation commitment after dietary copper deficiency. Unlike liver, GS and CPS-I are detected by immunofluorescence in all pancreatic hepatocytes. In situ hybridization revealed that all pancreatic hepatocytes contain GS and CPS-I mRNAs. The sizes of these two mRNAs in pancreas with hepatocytes are similar to those of the liver. The concomitant expression of GS and CPS-I genes in pancreatic hepatocytes may be attributed, in part, to the absence of portal blood supply to the pancreas vis-à-vis the lack of hormonal/metabolic gradients as well as to possible matrix homogeneity in the pancreas.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/genética , Expresión Génica , Genes , Glutamato-Amoníaco Ligasa/genética , Hígado/enzimología , Páncreas/enzimología , Animales , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Cobre/deficiencia , Técnica del Anticuerpo Fluorescente , Glutamato-Amoníaco Ligasa/análisis , Masculino , Hibridación de Ácido Nucleico , Páncreas/patología , ARN/genética , ARN/aislamiento & purificación , Ratas , Ratas Endogámicas F344 , Transcripción GenéticaRESUMEN
Sensitive and specific radiochromatographic methods to measure enzymatic activities of carbamyl phosphate synthetase I (CPS I) and ornithine transcarbamylase (OTC) were developed. The activities of these enzymes were assayed in frozen liver tissue obtained from 23 individuals with hyperammonemia caused by CPS I (five patients) and OTC deficiency (18 patients). In addition, livers of one aborted fetus with OTC deficiency and four normal individuals were studied. The assays use radioactive ornithine as a substrate followed by separation of citrulline formed in the reactions by HPLC and quantitation of the radioactivity in both amino acids by a radioactivity flow monitor or by a scintillation counter. Both CPS I and OTC assays were linear with respect to length of incubation time and concentration of tissue homogenate. The sensitivity of the methods allowed measurements of CPS I and OTC activities as low as 0.1 mumol/g/min on 5 mg of liver tissue and the diagnosis of CPS I or OTC deficiency could be established on as low as 0.5 and 0.05 mg of tissue, respectively. CPS I activity in different sections of four normal livers was 3.01 +/- 0.16 mumol/g/min (mean +/- SEM, n = 19) and OTC activity was 93.4 +/- 6.3 (mean +/- SEM, n = 19). Residual enzymatic activity could be detected and measured in the liver tissues of one of the five subjects with CPS I deficiency and in 14 of 19 subjects with OTC deficiency. OTC/CPS I activity ratio in normal liver tissue was 31.2 +/- 1.3 (mean +/- SEM, n = 19), whereas this ratio ranged from 343 to greater than 5000 in CPS I deficient livers and from less than 0.02 to 1.55 in OTC deficient livers.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/enzimología , Amoníaco/sangre , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Hígado/enzimología , Ornitina Carbamoiltransferasa/análisis , Errores Innatos del Metabolismo de los Aminoácidos/sangre , Carbamoil-Fosfato Sintasa (Amoniaco)/deficiencia , Cromatografía Líquida de Alta Presión , Humanos , Enfermedad por Deficiencia de Ornitina CarbamoiltransferasaRESUMEN
Immunohistochemical analysis of human liver (8 to 94 years) shows a compartmentation of ammonia-metabolizing enzymes across the acinus. The highest concentration of carbamoylphosphate synthetase (ammonia) is found in the parenchymal cells around the terminal portal venules. Glutamine synthetase is found in a small pericentral compartment two to three cells thick. In contrast to observations in rat liver, in human liver a well-recognizable intermediate zone can be distinguished in which neither enzyme can be detected. This intermediate zone is not yet established at the age of 8 years but can be recognized in livers from 25 years onward. Carbamoylphosphate synthetase can already be detected in the liver of human fetuses at 5 weeks of development. The enzyme distribution reveals a random heterogeneity among the hepatocytes, suggesting that not all hepatocytes start to accumulate carbamoylphosphate synthetase at the same time. From 9 weeks of development onward, the enzyme becomes homogeneously distributed throughout the liver parenchyma until at least 2 days after birth. Glutamine synthetase cannot be detected during this period. In addition, the definitive architecture of the acinus is not yet completed at birth. These results therefore support the idea that in human liver, metabolic zonation with respect to NH3 metabolism exists as it does in rat liver. Furthermore, the data show that this functional compartmentation becomes established concomitant with the development of the acinar architecture.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Amoníaco/análisis , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Glutamato-Amoníaco Ligasa/análisis , Hígado/enzimología , Feto/enzimología , Humanos , Inmunohistoquímica , Hígado/embriología , Distribución TisularRESUMEN
The first three steps of mammalian de novo pyrimidine biosynthesis are catalyzed by the multifunctional protein CAD, consisting of glutamine-dependent carbamylphosphate synthetase, aspartate transcarbamylase, and dihydroorotase. The intracellular distribution of CAD in two hamster cell lines, BHK 21 and BHK 165-23 (a strain in which the CAD gene was selectively amplified), was determined by differential centrifugation and by two different cytochemical immunolocalization methods. Ammonia-dependent carbamylphosphate synthetase I was found in both cell types at a concentration of 0.01% of the total cell protein, so its distribution was also determined as a control for possible cross-reactivity of the CAD antibody probes and as a mitochondrial marker. CAD was localized in the cytoplasmic compartment and almost completely excluded from the nucleus. A punctate staining pattern suggested that it was not uniformly dispersed throughout the cytosol (unlike typical soluble proteins) but was associated with subcellular organelles. Although there was a slight tendency for CAD to be localized in the vicinity of the nuclear envelope, the amount of staining was much less than expected from differential centrifugation, which showed that 30% of the protein was found in the nuclear fraction. No interactions with other subcellular components could be detected by centrifugation. It is possible, however, that CAD is associated with subcellular structures that cosediment with the nuclei. Despite a 150-fold increase in CAD concentration in the over-producing cells, the distribution of the protein was unaltered. CAD was not concentrated near the mitochondria where the next enzyme of the de novo pathway, dihydroorotate dehydrogenase, is localized, which indicates that the intermediate dihydroorotate is not channeled, but rather dissociates from CAD and diffuses through the bulk cellular fluid.
Asunto(s)
Amidohidrolasas/análisis , Aspartato Carbamoiltransferasa/análisis , Carbamoil-Fosfato Sintasa (Glutamina-Hidrolizante)/análisis , Citoplasma/enzimología , Dihidroorotasa/análisis , Complejos Multienzimáticos/análisis , Animales , Aspartato Carbamoiltransferasa/genética , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Carbamoil-Fosfato Sintasa (Glutamina-Hidrolizante)/genética , Fraccionamiento Celular , Línea Celular , Núcleo Celular/enzimología , Centrifugación por Gradiente de Densidad , Cricetinae , Dihidroorotasa/genética , Ensayo de Inmunoadsorción Enzimática , Técnica del Anticuerpo Fluorescente , Amplificación de Genes , Técnicas para Inmunoenzimas , Inmunohistoquímica , Microsomas/enzimología , Mitocondrias/enzimología , Complejos Multienzimáticos/genética , Urea/metabolismoRESUMEN
An indirect, competitive enzyme-linked immunosorbent assay for the quantitation of carbamoyl-phosphate synthetase I (ammonia) in rat liver has been developed. Homogenization of the liver in 1% sodium deoxycholate is used for complete solubilization of the enzyme. The detergent does not interfere with the method if diluted to a concentration of 0.01% or lower. The assay is applied to determine the amount of enzyme in control rats and in rats fed "cafeteria" or high-protein diets. Changes in the amount of carbamoyl-phosphate synthetase I (ammonia) paralleled changes in enzymatic activity.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Técnicas para Inmunoenzimas/métodos , Hígado/enzimología , Animales , Dieta , Masculino , Ratas , Ratas EndogámicasRESUMEN
Hepatocytes are induced in the pancreas of rats maintained first on a copper-deficient diet for 8 weeks and then on normal rat chow. These cells are morphologically identical to parenchymal cells of the liver. These hepatocytes contain two liver-specific proteins: carbamyl phosphate synthetase I, a mitochondrial matrix protein that participates in the conversion of ammonia to carbamyl phosphate; and urate oxidase, an enzyme that catalyzes the oxidation of uric acid to allantoin. In addition, we also present evidence indicating that dietary administration of ciprofibrate induces peroxisomal beta-oxidation pathway enzymes, while the levels of catalase are unaltered in pancreatic hepatocytes. These observations along with the previously published results further establish the identity of pancreatic hepatocytes to parenchymal cells of liver and clearly indicate that transdifferentiation of pancreatic cells to hepatocytes is associated with activation of several liver-specific genes.
Asunto(s)
Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Coristoma/patología , Hígado/citología , Páncreas/patología , Urato Oxidasa/análisis , Animales , Diferenciación Celular , Cobre , Inmunohistoquímica , Masculino , Microcuerpos/enzimología , Mitocondrias/enzimología , Ratas , Ratas Endogámicas F344RESUMEN
In adult rat liver, glutamate dehydrogenase is present in high concentrations around the terminal portal (zone 1) and hepatic (zone 3) veins, whereas its concentration is low in the intermediate zone. Although the size and staining intensity of the periportal glutamate dehydrogenase-positive compartment are less than those of the pericentral compartment, it can expand under appropriate endocrine conditions, leading to a homogeneous distribution. At birth, glutamate dehydrogenase is also homogeneously distributed. Glutamate dehydrogenase disappears from the periportal compartment during the first postnatal week and reappears in that compartment after weaning. These observations indicate an independent regulation of glutamate dehydrogenase levels in the periportal and pericentral zone. The size of the periportal glutamate dehydrogenase-containing zone is appreciably smaller than that of carbamoylphosphate synthetase, whereas the pericentral glutamate dehydrogenase-containing zone is appreciably larger than that of glutamine synthetase. The heterogeneous distribution of glutamate dehydrogenase suggests the possibility that, under normal conditions, deamination of glutamate prevails in the periportal compartment and amination of glutamate in the pericentral compartment.
Asunto(s)
Envejecimiento/metabolismo , Glutamato Deshidrogenasa/análisis , Hígado/enzimología , Animales , Carbamoil-Fosfato Sintasa (Amoniaco)/análisis , Diabetes Mellitus Experimental/enzimología , Fijadores , Glucocorticoides/farmacología , Glutamato Deshidrogenasa/metabolismo , Venas Hepáticas , Inmunohistoquímica , Hígado/efectos de los fármacos , Hígado/crecimiento & desarrollo , Vena Porta , Ratas , Ratas Endogámicas , Distribución TisularRESUMEN
The different turnover rates of rat liver mitochondrial enzymes make autophagy unlikely to be the main mechanism for degradation of mitochondria. Although alternatives have been presented, hepatocyte heterogeneity has not been considered. Lighter hepatocytes isolated in a discontinuous Percoll gradient contain more glutamate dehydrogenase (GDH) (half-life 1 day) and a more active autophagic system than heavier hepatocytes. The latter contain more carbamoyl phosphate synthase (CPS) and ornithine carbamoyl transferase (OTC) (half-lives 8 days) but less lysosomal activity. As expected, isolated autophagic vacuoles contain, relative to the mitochondrial content, 3-times less OTC and CPS than GDH, probably reflecting a faster lysosomal engulfment of mitochondria in the light hepatocytes (which contain more GDH). These data may explain some of the half-life differences of the enzymes studied.